Table 2.
Crude and adjusted rate ratios of skin or soft tissue complication associated with current use (3–30 days before the index date) of NSAIDs and paracetamol among varicella or zoster patients (reference no current use)
| Variables | Cases | Matched controls | Crude RR | Adjusted RR* (95% CI) |
|---|---|---|---|---|
| Primary varicella | ||||
| Number of subjects | 386 | 2402 | ||
| Current use of: | ||||
| NSAIDs % | 12 (3.11) | 14 (0.58) | 5.2 | 4.9 (2.1, 11.4) |
| Paracetamol % | 51 (13.21) | 246 (10.24) | 1.7 | 1.5 (1.0, 2.2) |
| Zoster disease | ||||
| Number of subjects | 681 | 2142 | ||
| Current use of: | ||||
| NSAIDs % | 57 (8.37) | 113 (5.28) | 1.6 | 1.6 (1.1, 2.4) |
| Paracetamol % | 146 (21.44) | 537 (25.07) | 0.8 | 0.8 (0.6, 1.0) |
RR, rate ratio.
Adjusted for all variables inTable 1.